Skip to main content

About Us
- Why Psychiatric Pharmacists?
- Psychiatric Pharmacists: Improving access, outcomes, and cost
- Information for Patients and Caregivers
- About AAPP
- Formerly CPNP
- General Information
- AAPP Member Profile
- Why Join AAPP
- AAPP Foundation
- Sponsorships
- Corporate Sponsors
- Sponsorship Opportunities
- News and Activities
- The AAPP Perspective
- Partnerships
Events
- 2026 Summit
- 2027 Annual Meeting
- Member-Only Virtual Events
- Communities Week
- Journal Club Series
- SUD Scoop
- Other Events
- Past Events
- Future Annual Meetings
- Regional/Other Events
- Find More Resources in My AAPP
Education+Resources
- Locate Valuable Resources
- Continuing Education (CE)
- Browse the Course Catalog
- Free CE
- Psychiatric Pharmacotherapy for Nurses and non-BCPP Pharmacists
- Browse Resources
- Mental Health Clinician
- Toolkits and Clinical Resources
- Resources for Community, Retail, and Ambulatory Care Pharmacists
- Resources for Patients and Caregivers
BCPP/BCPMP
- My Options
- Help Me Choose
- BCPP Exam Preparation
- Certification FAQ
- Preparatory Products
- 2026-2027 Psychiatric Pharmacotherapy Review-ACPE Credit
- Examination Preparation Journey
- Registration
- BCPP Recertification
- Recertification FAQ
- BCPP Recert Products
- Registration
- BCPMP Recertification
- Overview
- Find More Resources in My AAPP
- My Continuing Education
- BCPP Credit Planner
Career/Residency
- Future Psychiatric Pharmacists
- Why Psychiatry?
- How? Understanding the Career Path
- What? About the Job
- Where? Common Practice Settings
- What I Wish I Knew
- Employer Resource Center
- Training Opportunities
- Becoming a BCPP
- Residency Tips
- Residency Directory
- Fellowships
- Job Opportunities
- Hiring Landscape
- Job Listings (Career Center)
- Psychiatric Pharmacy Outlook
- RPD Survey Results
- PGY2 Competency Areas, Goals and Objectives
Practice
- Start a New Practice
- Employer Resource Center
- Outpatient Psychiatric Pharmacist Best Practice Model
- Practice Expansion Grant 2026
- Psychotropic Stewardship
- Introduction
- Implementation Toolkit
- The AAPP Outcomes Initiative
- Outcomes Research Grant
- Core Outcome Set for Psychiatric Pharmacists (COS-PP)
- Clinical Research Toolkit
- Writing Accountability Groups (WAGs)
Members
- Join or Renew
- Member Toolkit
- Member Directory
- Awards and Fellowship Program
- AAPP Documents and Reports
- Communities
- Volunteers and Leaders
- Board of Directors
- Past Presidents
- Committees & Task Forces
- Get Involved (Volunteer)
- Student Resources
- Pharmacy Student Hub
- Collegiate Chapters
Advocacy
- Intro to Psychiatric Pharmacists
- Overview and Profiles
- See the Research
- Presentation Resource
- AAPP Positions
- Policy Priorities
- Policy Statements and Briefs
- Advocacy Fact Sheets-Infographics
- The Evidence Base-AAPP Papers
- Taking Action
- Comment Letters
- Grassroots Advocacy Tools
- Coalitions
- AAPP Ambassador Program
- Patient Advocacy
My AAPP
Sign in

Advanced search

Email:

Password:

Forgot password Create new account

First-in-Class Drug for ADHD Wins FDA Approval

Triple reuptake inhibitor centanafadine is indicated for patients ages 6 years and older.

Learn More

About AAPP

The American Association of Psychiatric Pharmacists (AAPP) represents about 3,000 health care professionals. As members of a treatment team of health care professionals, psychiatric pharmacists make a difference in patient recovery and quality of life.

Highlights

AAPP 2027 Annual Meeting
2026 Summit
BCPP Resources
Education + Resources
Mental Health Clinician (MHC)
The AAPP Perspective
AAPP Foundation
Business Opportunities

My AAPP

My Profile
My BCPP Credit Planner
My Presentations and Exams
Opportunities for Involvement
Career Center

Contact AAPP

8055 O Street
Suite S113
Lincoln, NE 68510
T: 402-476-1677
info@aapp.org

© 2003-2026 aapp.org | All Rights Reserved | Terms of Use | Contact

AAPP websites use cookies to personalize and enhance your experience. By continuing to use the site, you agree to this collection. Learn more.